KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $1.2B
- YoY, 2025
- +28.9%
- 5-year CAGR
- +33.1%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $1.2B | +28.9% |
| 2024 | $946M | +21.5% |
| 2023 | $779M | +49.1% |
| 2022 | $522M | −12.0% |
| 2021 | $594M | +103.2% |
| 2020 | $292M | +43.9% |
| 2019 | $203M | +79.2% |
| 2018 | $113M | +128.9% |
| 2017 | $49M | +17,019.0% |
| 2016 | $289K | — |